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Despite the intensive study on the mechanism of action of membrane-active 
molecules such as antimicrobial and anticancer peptides, most of the biophysical work has 
been performed using artificial model systems, mainly lipid vesicles. The use of these 
systems allows full control of the experimental parameters and to obtain molecular-level 
detail on the action of peptides but the correlation with biological action is intangible. 
Recently several biophysical methodologies have been translated to studies using bacterial 
and cancer cells. Here we review biophysical studies on the mechanism of action of 
antimicrobial and anticancer peptides performed directly on cells. The data in these studies 
allow to correlate vesicle- and cell-based studies and fill the vesicle-cell interdisciplinary 
gap. 
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Over the years biophysicists have studied intensively the mode of action of 
membrane-active molecules. The need for quantitative data has driven these researchers to 
use artificial systems, mainly vesicles, so that full control of the experimental parameters is 
achieved. Vesicles are made of artificial mixtures of lipids, which means that the researcher 
controls the fluidity, the thickness, the concentration, the charge, and the chemical nature of 
the lipids, as well as the presence, or absence, of sterols. Depending on the mode of 
preparation of vesicles, unilamellar systems of controlled size or multilamellar systems are 
obtained. Moreover, there are methods that enable loading vesicles with chemical species 
such ions and fluorophores. 
 One of the very few limitations in work with vesicles is the serious difficulty of 
preparing vesicles of asymmetrical lipid bilayers. In cases in which asymmetrical bilayers 
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are needed, biophysicists resort to planar lipid bilayers totally or partially supported such as 
the SLM (Supported Lipid Bilayers) [1] or BLM (Black Lipid Membranes) [2], respectively. 
Vesicles prepared directly from biological membranes may lose their organization and were 
not generally adopted. 
 Vesicles and other artificial lipid bilayer systems enabled collecting massive amounts 
of molecular-level detail data on the action of antimicrobial peptides (AMPs). A reasonably 
well structured understanding of the molecular events implied in membrane perturbation and 
disruption by AMPs has emerged. Most AMPs have high affinity for anionic lipid 
membranes, change conformation upon contact with the lipids, and undergo critical events at 
specific local peptide-to-lipid ratios. These critical events are typically a change in 
orientation and/or oligomerization in the membrane [3], so they occur at high membrane 
coverage by the peptides. 
  The details of AMP-induced membrane disruption in bacteria are rarely known and 
the validity of extrapolating knowledge on AMP action in vesicles to bacteria is largely 
elusive. Bridging the gap between microbiology and biophysics remains a challenge yet to 
be met. Being up to the challenge is a matter of both biophysicists and microbiologists 
leaving their reductionist disciplinary approach engage interdisciplinary work, not an 
intrinsic limitation of the techniques and methodologies available to tackle the gap. 
 It is our purpose with this discussion paper to demonstrate that quantitative 
biophysical studies of AMPs in bacteria are possible and important recent advances have 
been achieved to elucidate the molecular events that take place at bacterial membranes, and 
their (dis)similarities with their counterparts in vesicles. 
 
LIPID BILAYERS: SIMPLE BUT UBIQUITOUS 
 
Over millions of years of molecular, cellular, and species evolution, it is amazing that cell 
membranes have converged, without exception, to lipid bilayer-based structures. The 
chemical nature of the lipids varies, the presence of non-lipid molecules varies, charge and 
fluidity vary, but lipid bilayers are the essence of any biological membrane. This makes lipid 
bilayers the gold reference standard model for biological membranes. Biophysicists praise 
their simplicity, microbiologists undervalue them but their importance is not ignored. 
 If AMPs accumulate in the bacterial membranes as in vesicles or not, if they change 
conformation and supra-molecular organization as in vesicles or not, if they disrupt 
membrane integrity as in vesicles or not, if they collapse bacteria as they collapse the 
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morphology of vesicles or not, etc. are matters of vivid debate. Discussions are fueled more 
by intuition rather than objective evidence-based opinion. However, important yet dispersed, 
data in the literature is frequently overlooked. 
 
BACTERIAL MEMBRANES: MORE THAN BILAYERS 
 
Bacterial membranes are complex (Figure 1) when compared to human cells for instance. In 
Gram-negative bacteria the presence of a highly organized lipopolysaccharide (LPS) layer 
constitutes a barrier difficult to mimic in artificial systems. In Gram-positive bacteria is not 
possible to isolate the intact peptidoglycan wall and use it as single component of an 
artificial system. Therefore, it is not possible to work with perfect mimics of LPS 
membranes and peptidoglycan shells. This prevents researchers from working with isolated 
lipid bilayers, isolated layers of LPS and isolated peptidoglycan meshes forming a closed 
shell. It is thus impossible for biophysicists to extrapolate the biological action of AMPs 
from the data obtained with realistic models of each membrane component. The only way 
for biophysicists to unravel the biological action of AMPs is to apply their techniques 
directly on bacteria, which demands adaptations and methodological refinement. Although 
not trivial, successful adaptations have been reported for Atomic Force Microscopy (AFM), 
Fluorescence Spectroscopy, Circular Dichroism (CD), Infrared Spectroscopy, among others 
[4-7]. Some of these studies will be visited in the following sections. 
 Although there are no artificial systems that match the supramolecular organization 
of LPS and peptidoglycan in membranes, it is possible to work with extracts of biological 
components of bacterial membranes. Extracts are not realistic from the structural point of 
view but serve as simple models to study the interaction of peptides with these kinds of 
molecules. Given the architecture of bacterial membranes, a pertinent question to be asked 
is: can LPS (Gram-negative bacteria) and peptidoglycan (Gram-positive bacteria) serve as 
electrostatic barriers that capture AMPs and prevent their interaction with the inner lipid 
bilayer? Or, on the contrary, these layers saturate and cannot retain excess AMPs, which 
remain available to permeabilize the inner bilayers? In the end, answering these questions is 
a matter of concentrations (of AMPs and membrane components) and affinities of AMPs 
towards the different membrane components. 
 Omiganan, an AMP of clinical relevance [8, 9], was studied for its interaction with 
peptidoglycan extracts quantitatively. It was observed that there is extensive interaction 
between the peptide and peptidoglycan. While the results could, at first glance, leave the 
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impression that Gram-positive bacteria cell walls trap AMPs and prevent them from 
interacting with lipid membranes, in typical efficacy assays the concentration of 
peptidoglycan is very small and the quantity of peptide need to saturate the bacterial wall is 
negligible. Both aqueous phase and membrane-bound peptide concentrations are, in practice, 
the same, in the presence or absence of the wall, defeating its role as peptide trap. Henriques 
et al. [10] used Limulus amebocyte lysate to evaluate the binding of the AMP Sub3 to LPS 
and lipotheicoic acids (LTA). The data was used to propose a model of action of Sub3 in 
which it targets the outer membrane of bacteria through electrostatic attractions, causing 
permeation. The interaction with the inner membrane is not lytic: Sub3 translocates the inner 
membrane to bind to intracellular targets. The 21 kDa peptide based on the N-terminal 
region of the neutrophil bactericidal/permeability-increasing protein (rBPI21) binds LPS 
aggregates [11, 12], which was hypothesized to facilitate LPS clearance by macrophage 
phagocytosis and/or blocking of LPS specific receptor recognition [12]. Later, the same 
authors confirmed by AFM Force spectroscopy that soluble LPS decrease the interaction of 
rBPI21 with bacteria, especially S. aureus [13]. 
 
BACTERIA IN BIOPHYSICAL STUDIES 
 
Several groups translated biophysical methodologies usually applied in artificial 
model systems to bacteria to study the molecular events that take place when AMPs interact 
with bacterial membranes (Table 1). This trend has been growing and important 
contributions have been published recently. In fact, this trend encompasses the fast 
development of cell biophysics in general. Whole-cell Nuclear Magnetic Resonance (NMR) 
[14], AFM [15], single particle tracking microscopies [16], isothermal  titration calorimetry 
[17], zeta-potential light scattering [18] and fluorescence spectroscopy [19] are some 
examples of biophysical techniques recently applied to study molecular events directly on 
cells. 
 The specific case of AMPs action in bacteria has been addressed by Alves et al. [4] 
who studied E. coli morphologic collapse induced by two AMPs by AFM in standard 
conditions of bacterial growth and density. The collapse of the structure of the cell occurs at 
an AMP concentration that coincides with the minimum inhibitory concentration, MIC. 
Moreover, this is concomitant with electroneutralization of bacterial surfaces, as measured 
by zeta-potential light scattering. This parallels the action of AMP in vesicles, in which 
membrane coverage and electroneutralization has been quantitatively determined [20]. The 
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similarities observed between vesicles-based and bacteria-based work, even when precise 
quantitative reasoning is applied, has led to the proposal that biological action parameters, 
such as the MIC, can be estimated within reasonable limits from data on lipid affinity 







γL is the volumic mass of the lipids, σ is the peptide:lipid ratio on the saturated membrane 
itself, and Kp is the peptide lipid-aqueous environment partition constant. This thesis is 
detailed in references [3, 18, 21]. 
 The need for peptides to saturate bacterial membranes and to cause permeabilization 
and inactivation explains why it is so rare to find AMP with MIC below 1 µm, an intriguing 
question that upsets peptide drug medicinal chemists. It is hypothesized that AMP with MIC 
below 1 µM have targets other than the membranes. Some may translocate membranes [22] 
and reach intracellular targets. 
 Independent studies by other groups corroborated the finding that AMPs act on 
bacteria under the same general principles as in vesicles. Stella’s group has recently 
demonstrated [7] that the AMP PMAP 23 is active only when bound peptides completely 
saturate bacterial membranes, which occurs at micromolar total peptide concentration under 
the experimental conditions used to measure bactericidal activity. Stella et al. used steady-
state and time-resolved fluorescence spectroscopy. Using a different technique, CD, 
Romanelli [5], with a completely independent study from the others previously described, 
also found important similarities between AMPs action in vesicles and bacteria: AMPs 
change conformation upon binding to membranes. LPS in bacteria are able to induce the 
conformational changes also observed in lipid bilayer vesicles. 
 The question remains on if it is possible for peptides to reach micromolar 
concentrations in vivo in a biological or pharmacological context. However, it is known that 
human neutrophil peptide 1, HNP-1, for instance, may reach concentrations between 30 µM 
and nearly 50 µM during infection [23]. For topical administration, reaching concentrations 
above µM is not a problem but for systemic administration this may be a challenge. Whilst 
the toxicology of peptides is usually not very stringent, the fast clearance from plasma does 
not favor high circulating concentration [24].  Chemical modification of peptides to improve 
pharmacokinetics is possible but it is still a challenge [24, 25]. 
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 The process of membrane permeabilization by AMPs was studied from the kinetic 
point of view by Freire et al. [26]. The action of an AMP on E. coli was assumed to be 
described by two consecutive steps: cooperative binding to the membrane and 
permeabilization. An innovative variant of Fluorescence Activated Cell Sorting (FACS), 
time-resolved FACS, was used in association to the Syto-9/Propidium Iodide “live-dead” 
assay  [27] to follow the kinetic course of membrane permeabilization and allow retrieving 
the kinetic constant, associated to membrane association and subsequent membrane 
permeabilization as well as a cooperativity factor. Although the results are in general 
agreement with AMPs mechanism of action previously proposed based on vesicle work, the 
results varied among strains meaning that the details of the AMP action, mainly 
cooperativity, depends on the specific membrane composition. It is worth highlighting that a 
mutant strain with LPS having very short saccharide moieties are resistant to the AMP. This 
probably results from low electrostatic attraction of the AMP at the bacterial outer surface 
and/or abrogation of the conformational changes that trigger membrane permeabilization 
[5], which prevents the AMP from reaching and perturbing the inner lipid bilayer. This is in 
agreement with proposals that AMPs may fuse or at least perturb outer and inner membranes 
of bacteria [12]. Gee et al. [6] compared the action of a fluorescently labeled AMP in 
vesicles and bacteria using time-lapse fluorescence lifetime imaging and assigned the 
differences to this dynamic interplay between the effects of AMP in inner and outer 
membranes. A study of Dathe’s group [28] with a cyclic peptide had shown that the LPS in 
E. coli are important for the peptide binding and partition. Absence of bacterial coverage by 
the AMP abrogates membrane permeabilization. The interaction with the outer membrane 
modulates the guidance of the AMP to the inner membrane, which is determinant for 
antimicrobial activity. 
 
FROM BACTERIA TO TUMOURS 
 
 Following the discovery that the surface of cancer cells is rich in anionic lipids, a 
great deal of effort is being concentrated in developing AMPs as anticancer peptides, ACPs 
[29]. Very few studies are available on the action of ACPs on tumor cell membranes, some 
of which are summarized in Table 2. Only a subset of AMPs displays anticancer activity and 
there is strong controversy on whether AMPs and ACPs act the same way [30]. The outer 
surfaces of cancer cell membranes are not as anionic as in bacteria. Given the role of 
electrostatics in the mode of action of AMPs it is legitimate to question if ACPs follow the 
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mechanism of AMPs to permeabilize membranes. In particular, there were concerns that 
ACPs could accumulate on the surface of cancer cells to the extent observed in bacteria. 
Gaspar et al. [31] used zeta-potential light scattering spectroscopy with lung carcinoma 
A549 cells to demonstrate that ACPs SVS-1 is active at stages preceding membrane 
neutralization, in contrast with AMPs that target membranes. HNP-1 has a plethora of 
effects on cellular morphology and stiffness, membrane ultrastructure and charge on solid 
and hematological tumor cells [32]. For HNP-1, AFM and zeta-potential measurements 
show a preferential binding to solid tumor cells from human prostate adenocarcinoma when 
compared to human leukemia cells. AFM in particular revealed induction of apoptosis 
concomitant with cellular membrane defects at very low peptide concentrations.  
In bacteria, saturation of outer membranes leads to permeabilization and AMP 
interaction with the inner membrane (Figure 2). ACPs appear to diverge from the mode of 
action of most AMP, as they translocate membranes prior to saturation of membranes and 
reach intracellular targets (Figure 2).  In these cases, killing may occur by interaction with 
intracellular targets. It is worth reminding that AMPs are potential Cell-Penetrating Peptides, 
CPPs [22]. ACPs seem to result from the combination of antimicrobial and cell-penetrating 




Despite being only a small number of studies when compared to vesicle-based studies, cell-
based biophysical studies on the action of AMPs and ACPs constitute important seminal 
work with a clear growing trend. Recent data sheds light on the molecular-level detail of the 
mechanism of action of AMPs and ACPs in cells. The vesicle-cell interdisciplinary gap is 
finally being bridged. The similarities and dissimilarities between the action of AMPs and 
ACPs in vesicles and cells are finally being unraveled (Figure 2). This demands power to 
adapt techniques and methodologies, as well as commitment of biophysicists to accept the 
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Table 1 – Selected recent illustrative papers on the application of biophysical techniques directly in bacteria 
to study the action of AMP 
 








Zeta-potential measurements of live 
bacterial cells in the presence of AMP. 
At MIC, the surface of the cells 
becomes neutral and the membranes 
collapse. Quantitative surface 











Direct imaging of the action of the lytic 





E. coli and S. 
aureus 
Antibacterial efficiency follows the 
affinity for bacterial membrane and is 














E. coli and S. 
aureus 
Sub3 targets the anionic outer 
membrane of Gram-negative bacteria 
by electrostatic attraction, permeates 
the outer membrane, and translocates 
the inner membrane to reach 
intracellular targets. A similar 
mechanism is proposed for Gram-
positive, with lipotheicoic acids 
replacing the liposaccharides as 







PMAP-23 E. coli 
The number of AMP required to kill a 







Study of AMP conformational changes 















E. coli and S. 
aureus 
Surface perturbation on cells is 
followed by lysis. rBPI21 has a binding 
pocket that may participate on the 





pepR E. coli 
Describes and analizes the kinetics of 
bacterial AMP-induced 
permeabilization.  Quantitative kinetic 
parameters on AMP binding to 
bacterial membrane, cooperativity and 
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Table 2 - Selected recent illustrative papers on the application of biophysical techniques directly in tumor 
cells to study the action of ACP 


















562, Jurkat and 
MOLT-4) 
The cytotoxic activity of the peptide 














FACS and microscopy techniques 
allowed the observation of 
mitochondrial morphology alterations 









Cell death occurred by induced lysis of 
cell membrane mediated after 48h of 













The killing mechanism of polybia-MPI 
AMP involves plasma membrane 
perturbation. Human cancer cells died 
after acute injury and bursting in 



















Disruption of cancer cell membrane 
occurs via pore formation and was 
monitored with microscopy techniques. 
Cell membrane surface charge was 
measured with Zeta-potential and 
showed that cell death precedes full 

















AMP-induced cell death over time was 








Cancer cell death results mainly from 
cell surface damage. Cellular 
biomechanical properties are also 








CPs induced S cell-cycle arrest. [41] 
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The inhibition of PC-3 cellular 
proliferation and apoptotic death was 
followed with flow cytometry and 











Microscopy techniques were used for 
evaluating peptide’s selectivity, 















Cellular death, morphology, stiffness, 
and membrane ultrastructure 
and charge was followed using FACS, 

























Cell death was evaluated by the loss of 
mitochondrial membrane potential, 
chromatin condensation and 
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FIGURE 1 - Schematic view of bacterial membranes and their models. Large unilamellar 
vesicles of lipid bilayers mimic the inner membrane of bacterias both in structure and 
composition. LPS and peptidoglycan aggregates mimic composition of outer bacterial 
membranes but not structure, which limits their application to AMP binding studies 
 
FIGURE 2 – Permeabilization of vesicles and bacteria usually demands saturation of 
membranes. In standard antibacterial activity assays this occurs in or above micromolar 
concentration ranges. In bacteria, saturation of outer membranes leads to permeabilization and 
AMP interaction with the inner membrane. Some AMPs are able to translocate membranes at 
lower concentrations and reach the interior of vesicles or bacteria. In these cases, killing may 
occur by interaction with intracellular targets. This mechanism is more often associated to ACP. 
 
Question: are the figure original ones or taken from previous manuscripts. In this case were 
the two figures some how modified? If not you need permission for their use. 
Moreover the lettering in the figures has to be increased as they are hardly readable and the 
figures cannot be significantly increased in the text online.  
 
Answer: Both figures are originals and the respective lettering is now increased. 
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Schematic view of bacterial membranes and their models. Large unilamellar vesicles of lipid bilayers mimic 
the inner membrane of bacterias both in structure and composition. LPS and peptidoglycan aggregates 
mimic composition of outer bacterial membranes but not structure, which limits their application to AMP 
binding studies.  
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Permeabilization of vesicles and bacteria usually demands saturation of membranes. In standard 
antibacterial activity assays this occurs in or above micromolar concentration ranges. In bacteria, saturation 
of outer membranes leads to permeabilization and AMP interaction with the inner membrane. Some AMPs 
are able to translocate membranes at lower concentrations and reach the interior of vesicles or bacteria. In 
these cases, killing may occur by interaction with intracellular targets. This mechanism is more often 
associated to ACP.  
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